Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Young entrepreneurs need to think small

26 March 2013

By Stephen Caddick, Vice-Provost (Enterprise) at UCL
Small is beautiful – and nowhere more so than in Tech City. The area is defined, by the startups and small, rapidly growing companies that cluster there; some 1300 tech companies charged with dynamism and entrepreneurial energy. 

Read the full article at techcitynews.com